Raiden Science Foundation

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

Tommy Pham

Phone

9715331984

Tax Period

2025-01-01 to 2025-12-31

Raiden Science Foundation, founded in 2021, is a small nonprofit in the Diseases & Disorders sector that reported $369K in total revenue in fiscal year 2025. Revenue surged 174% from the prior year, signaling strong growth momentum. The organization ran a surplus of $115K, a strong 31% operating margin.

Mission

Harness the power of community to innovate treatments for rare diseases, starting with UBA5.

Program Service Accomplishments

Program 1

Expenses: $211,595 Revenue: $372,387

1) We showed via proof of concept that the gene replacement therapy does work at restoring UBA5 levels,2) We initiated a drug re-purposing program for UBA5 at Oregon Health & Science University, 3) We established a partnership with Coriell Institute to create the first-ever UBA5 biobank, 4) We partnered with Baylor College of Medicine to develop complex UBA5 disease models, and 5) We successfully activated 2 fundraising campaigns - Run4Raiden and Kombat4Rare

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $372,387

Program Service Revenue $0

Investment Income $-344

Other Revenue $-2,714

TOTAL REVENUE $369,329

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $1,074

Program Expenses $211,595

Other Expenses $254,813

TOTAL EXPENSES $254,813

Year-over-Year Comparison

	2025	2024	Change
Revenue	$369,329	$134,549	+1.7%
Expenses	$254,813	$252,733	+0.0%
Net Income	$114,516	$-118,184	-2.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Amber Allen	Director	0.00	Director	$0	$0	$0
Michael Lin	Director	0.00	Director	$0	$0	$0
Kori Vyse	Director	0.00	Director	$0	$0	$0
Tommy Pham	President	10.00	Officer	$0	$0	$0
Linda Pham	Secretary	10.00	Officer	$0	$0	$0
Chris Andon	Treasurer	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$369,329	$254,813	$747,010	$114,516
2024	$134,549	$252,733	$632,494	$-118,184
2023	$478,617	$65,587	$750,678	$413,030
2022	$348,349	$14,084	$337,649	$334,265